Spanish Biotech Database

NEW YORK, Dec. 20, 2018 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that the European Patent Office has granted a European Patent for the Company's proprietary dual-mechanistic therapy Lorexys(TM) for hypoactive sexual desire disorder. A corresponding patent was previously... Read more ››

By: PR Newswire Association LLC. - 20 Dec 2018

Novo Nordisk A/S - Share repurchase programme

By: Nasdaq / GlobenewsWire - 17 Dec 2018

Protech Home Medical Acquires Riverside Medical and Central Oxygen

By: Nasdaq / GlobenewsWire - 17 Dec 2018

Related companies: PHARMA MAR, S.A.

Oryzon to join the IBEX Small Cap Index

By: Nasdaq / GlobenewsWire - 17 Dec 2018

Related companies: Oryzon Genomics, S.A.

Q3 Medical Devices Limited Announces its Intention for a Listing on the Main Board of the Stock Exchange of Hong Kong Limited

DUBLIN, Dec. 17, 2018 /PRNewswire/ -- A little over a year after raising over EUR 28 million in a private placement, Q3 Medical Devices Limited ("Q3 Medical" or the "Company") based in Dublin, Ireland today announced a new initiative to raise EUR 50 million in a Pre-IPO round that will prepare... Read more ››

By: PR Newswire Association LLC. - 17 Dec 2018

Related companies: Group K Diagnostics, Inc.

Virbac : Declaration of the number of shares and voting rights as of November 2018, 30.

By: Nasdaq / GlobenewsWire - 05 Dec 2018

Actress, Playwright And Advocate Danai Gurira Partners With Johnson & Johnson To Help End HIV/AIDS As She Addresses Global Citizen And Visits HIV Clinical Trial In South Africa

JOHANNESBURG, Dec. 3, 2018 /PRNewswire/ --

By: PR Newswire Association LLC. - 03 Dec 2018

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Spain?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

May 2019
- Zurich: The Pharma Licensing Negotiation Course
- Zurich: Pharma-Biotech Product & Company Valuation
- Zurich: The Pharmaceutical Out-licensing Course

See Events »

Add an Event »

Latest company news

B. Braun Announces $1 Billion Investment to Alleviate IV Fluid Shortages in the U.S. Healthcare System
14 May 2019 (Nasdaq / GlobenewsWire)

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
13 May 2019 (Nasdaq / GlobenewsWire)

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019
09 May 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Sanofi: Availability of the Pre-quarterly Results Communication

UPDATE - Immucor Announces Health Canada Approval for Echo Lumena™; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs

ALK appoints new Head of Product Supply

B. Braun’s OnGuard® CSTD Qualifies as an Effective Barrier for Vapor Release Based on the NIOSH Draft Universal Protocol

Novo Nordisk A/S - Share repurchase programme

Virbac : Declaration of the number of shares and voting rights as of December 2018, 31.

Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs

Protech Home Medical Announces Share Consolidation and New Stock Symbol

Novo Nordisk A/S: Share repurchase programme

ALK – Financial calendar for the 2019 financial year

S1 Biopharma Granted Patents for Lorexys(TM) in Europe and Asia for Treatment of Hypoactive Sexual Desire Disorder

Novo Nordisk A/S - Share repurchase programme

Protech Home Medical Acquires Riverside Medical and Central Oxygen

Oryzon to join the IBEX Small Cap Index

Q3 Medical Devices Limited Announces its Intention for a Listing on the Main Board of the Stock Exchange of Hong Kong Limited

ALK upgrades its full-year financial outlook due to accelerated sales

Novo Nordisk A/S - Share repurchase programme

CEO of Group K Diagnostics Nominated to the Philadelphia Startup Leaders Board

Virbac : Declaration of the number of shares and voting rights as of November 2018, 30.

Actress, Playwright And Advocate Danai Gurira Partners With Johnson & Johnson To Help End HIV/AIDS As She Addresses Global Citizen And Visits HIV Clinical Trial In South Africa

Looking for companies outside of Spain?

Partners

Upcoming Life Sciences Events

Latest company news